• Club Jules Gonin

      ASRS Logo

     

      

    Macula Society Logo

    In conjunction with the American Society of Retina Specialists, the Macula Society, the Retina Society and Club Jules Gonin

    The Art + Science of Retina + Vitreous

    Friday and Saturday, October 26 - 27
    McCormick Place, Chicago, IL

    Friday, October 26

    7:00
    AM
    Continental Breakfast  
    8:00
    AM
    Welcome and Introductions Richard F. Spaide, MD
    Mark S. Humayun, MD, PhD

    Section I: The Art of Vitreoretinal Surgery
    Moderators: John S. Pollack, MD and David N. Zacks, MD, PhD

    8:05
    AM
    Treatment of Persistent Hypotony in Eyes with Successfully Treated Proliferative
    Vitreoretinopathy
    Tarek S. Hassan, MD
    8:10
    AM
    Butterfly Sutures for Temporary Closure of Sclerotomies Claus Eckardt, MD
    8:15
    AM
    Top 3 Avoidable Problems Leading to Redetachment Steven T. Charles, MD
    8:20
    AM
    Pearls for Large Macular Holes Carl C. Claes, MD
    8:25
    AM
    Tips for Myopic Eyes Hiroko Terasaki, MD

    Section II: Vitreoretinal Surgery, Part I
    Moderators: Maria H. Berrocal, MD and John W. Kitchens, MD

    8:30
    AM
    A New Way to Close Holes and Breaks Stanislao Rizzo, MD
    8:37
    AM
    Hypersonic Vitrectomy: Continued Clinical Experience and Technical Improvements Carl C. Awh, MD
    8:44
    AM
    Development of a Deep Learning System for Digitally Enhanced Internal Limiting Membrane Peeling Kazuaki Kadonosono, MD
    8:51
    AM
    Final Visual Acuity, Not Amount of Improvement, Must Be the Measure of Our Success in
    Epiretinal Membrane Surgery
    Colin A. McCannel, MD
    8:58
    AM
    Management of Complications Correlated with the Use of Intraocular Tamponade Grazia Pertile, MD
    9:05
    AM
    Vitrectomy for Diabetic Macular Edema: Why, How, and When Gaurav K. Shah, MD
    9:12
    AM
    Myopic Foveoschisis Ramin Tadayoni, MD, PhD

    The Charles L. Schepens, MD Lecture

    9:19
    AM
    Introduction of the 2018 Charles L. Schepens, MD Lecture David W. Parke II, MD
    9:24
    AM
    Developing Therapies for AMD: The Art and Science of Problem-solving Joan W. Miller, MD
    9:44
    AM
    REFRESHMENT BREAK and RETINA EXHIBITS  

    Section III: The Business of Retina
    Moderator: Geeta A. Lalchandani-Lalwani, MD

    10:29
    AM
    Advocating for Profession and Patients Sohail J. Hasan, MD, PhD
    10:34
    AM
    Retinal Malpractice Issues: The 30-Year OMIC Experience George A. Williams, MD
    10:41
    AM
    MACRA and Beyond William L. Rich III, MD, FACS
    10:48
    AM
    Efficient Workflow Dennis P. Han, MD

    Section IV: My Best Medical Retina Cases
    Moderator: William F. Mieler, MD

    10:55
    AM
    Case Presentation David Sarraf, MD
    10:58
    AM
    Discussion  
    11:01
    AM
    Case Presentation K. Bailey Freund, MD
    11:04
    AM
    Discussion  
    11:07
    AM
    Case Presentation Lee M. Jampol, MD
    11:10
    AM
    Discussion  
    11:13
    AM
    Case Presentation Anita Agarwal, MD
    11:16
    AM
    Discussion  
    11:19
    AM
    Case Presentation William F. Mieler, MD
    11:22
    AM
    Discussion  

    Section V: Medical Retina, Part I
    Moderators: Paul Sternberg Jr., MD

    11:25
    AM
    Port Delivery Phase 2 LADDER AMD Study Results Carl D. Regillo, MD, FACS
    11:32
    AM
    Subthreshold Laser Therapies for Diabetic Macular Edema: A Review of All Subthreshold Laser Technologies Available to Treat DME Elias Reichel, MD
    11:39
    AM
    Micropulse Laser vs. Photodynamic Therapy for Central Serous Chorioretinopathy Jay K. Chhablani, MBBS
    11:46
    AM
    Time-Elapsed Studies of the Retinal Capillaries in Clinical Vascular Disease Using Adaptive Optics: What Do They Tell Us? Richard B. Rosen, MD
    11:53
    AM
    Optic Nerve Damage Due to Increased IOP Secondary to Dexamethasone Implant Michael A. Singer, MD

    Section VI: Special Lecture
    Moderator: Richard F. Spaide, MD

    12:00
    PM
    Machine Interpretation of Fundus Photographs Dale Webster, PhD 
    12:12
    PM
    LUNCH and RETINA EXHIBITS  

    Section VII: Uveitis
    Moderator: Daniel F. Martin, MD

    1:37
    PM
    Vitrectomy and Uveitis Janet Louise Davis, MD
    1:44
    PM
    Drug-Induced Uveitis Emmett T. Cunningham Jr., MD, PhD, MPH
    1:51
    PM
    Polymerase Chain Reaction Russell N. Van Gelder, MD, PhD
    1:58
    PM
    Three Pearls for Uveitis Narsing A. Rao, MD
    2:05
    PM
    Uveitis Case Panel Discussion
    Panel Moderator: Sunil K. Srivastava, MD
    Panelists: Nisha Acharya, MD; Hatice N. Sen, MD; Albert T. Vitale, MD; Steven Yeh, MD
     

    Section VIII: My Coolest Surgical Video
    Moderator: Masahito Ohji, MD
    Panelists: Jorge G. Arroyo, MD; Sophie J. Bakri, MD; Susanne Binder, MD; Allen C. Ho, MD; Edwin Hurlbut Ryan Jr., MD; Amir H. Kashani, MD, PhD

    2:25
    PM
    Internal Limiting Membrane Repositioning for Macular Hole
    Due to Rupture of Retinal Macroaneurysm
    Yuki Morizane
    2:27
    PM
    Discussion  
    2:30
    PM
    Surgical Pupilloplasty for Secondary Angle Closure Glaucoma
    Induced by Silicon Oil Tamponade
    Priya Narang, MS
    2:32
    PM
    Discussion  
    2:35
    PM
    Use of Intraoperative OCT in Ensuring Optimal Array Retina Contact
    During Argus II Implantation Surgery
    Young Hee Yoon, MD
    2:37
    PM
    Discussion  
    2:40
    PM
    What to do When Your Fluid/Air Exchange Doesn’t Work? Gustavo Matias Huning, MD
    2:42
    PM
    Discussion  
    2:45
    PM
    Foldable Subretinal Scaffold with Stem Cell Derived RPE in GA Amir H. Kashani, MD, PhD
    2:47
    PM
    Discussion  
    2:50
    PM
    Audience Vote  

    Section IX: Pediatric Retina
    Moderator: R. V. Paul Chan, MD

    2:52
    PM
    Anti-VEGF for ROP: What Drug and What Dose? Robert L. Avery, MD
    2:59
    PM
    Clinical Features and Management of “Crunch” Detachments following Anti-VEGF Treatment for ROP Antonio Capone Jr., MD
    3:06
    PM
    Repair and Regeneration Wnt Signaling: What and Why Michael T. Trese, MD
    3:13
    PM
    Anti-VEGF Treatment for ROP: Clinical Trials and Phenotypic Differences Worldwide Mary Elizabeth Hartnett, MD, FACS
    3:20
    PM
    Pediatric Retina Panel
    Panel Moderator: Philip J. Ferrone, MD
    Panelists: Audina M. Berrocal, MD; Cagri G. Besirli, MD; Kimberly A. Drenser, MD; G. Baker Hubbard, MD
     
    3:35
    PM
    REFRESHMENT BREAK with the EXPERTS and RETINA EXHIBITS  

    BREAK with the EXPERTS
    Moderators: M. Gilbert Grand, MD and Andrew J. Packer, MD
    3:35 PM

    AMD (Dry) Marco A. Zarbin, MD, PhD, FACS
    Amd (Wet) David M. Brown, MD
    Jeffrey S. Heier, MD
    Business of Retina Richard A. Garfinkel, MD
    William L. Rich III, MD, FACS
    Reginald J. Sanders, MD
    George A. Williams, MD
    Diabetic Retinopathy Susan B. Bressler, MD
    Jennifer K. Sun, MD
    Gene Therapy Mark E. Pennesi, MD, PhD
    Intraocular Tumors Timothy G. Murray, MD, MBA
    Machine Learning and Artificial intelligence Aaron Y. Lee, MD
    Macular Holes John T. Thompson, MD
    New Instrumentation David R. Chow, MD
    OCT Angiography Caroline R. Baumal, MD
    Ocular Imaging Amani Fawzi, MD
    David Sarraf, MD
    Pediatric Retinal Disease Audina M. Berrocal, MD
    Philip J. Ferrone, MD
    Retinal Detachment Gary W. Abrams, MD
    J. Michael Jumper, MD
    Hiroko Terasaki, MD
    Vascular Occlusions Michael S. Ip, MD
    Ingrid U. Scott, MD, MPH

    Section X: Late Breaking Developments, Part I
    Moderators: Mark S. Humayun, MD, PhD
    Panelists: David S. Boyer, MD; Alexander J. Brucker, MD; Baruch D. Kuppermann, MD, PhD

    4:20 PM Relentless Long-term Progression of Hydroxychloroquine Retinopathy Michael F. Marmor, MD
    4:25 PM Panel Discussion  
    4:28 PM Visual Function after Anti-VEGF Therapy for Macular Edema due to Central Retinal Vein Occlusion: SCORE2 Trial Results Ingrid U. Scott, MD, MPH
    4:33 PM Panel Discussion  
    4:36 PM 24-month Evaluation of Fluocinolone Acetonide Intravitreal Insert Treatment for Non-Infectious Posterior Uveitis Quan Dong Nguyen, MD
    4:41 PM Panel Discussion  
    4:44 PM Sub-Threshold Nanosecond Laser Intervention in Age-Related Macular Degeneration: The LEAD Randomized Controlled Clinical Trial Robyn H. Guymer, MBBS
    4:49 PM Panel Discussion  
    4:52 PM First Results of Photovoltaic Vision Restauration in Atrophic Dry Age-related Macular Degeneration Jose A. Sahel, MD
    4:57 PM Panel Discussion  
    5:00 PM New Low-cost Intravitreal Biosimilars (Bevacizumab and Ranibizumab) for Retinal Vascular Diseases Alay S. Banker, MD
    5:05 PM Panel Discussion  

    Section XI: First-time Results of Clinical Trials
    Moderator: Julia A. Haller, MD

    5:08 PM 26 Week Results of the Phase I Study to Evaluate Safety & Tolerability of RGX-314 Gene Therapy in nAMD Subjects Jeffrey S. Heier, MD
    5:15 PM Safety and Efficacy of Abicipar in Patients with Neovascular Ageā€related Macular Degeneration Rahul Khurana, MD
    5:22 PM Simultaneous Inhibition of VEGF and Ang-2 with Faricimab in Neovascular AMD: STAIRWAY Phase 2 Results Arshad M. Khanani, MD
    5:29 PM Brimonidine DDS Safety and Efficacy in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration William R. Freeman, MD
    5:36 PM Closing Remarks Mark S. Humayun, MD, PhD
        Richard F. Spaide, MD

    Saturday, October 27

    7:00
    AM
    Continental Breakfast  
    8:00
    AM
    Opening Remarks Richard F. Spaide, MD
    Mark S. Humayun, MD, PhD

    Section XII: Imaging
    Moderator: Brandon J. Lujan, MD and Amani Fawzi, MD

    8:05
    AM
    Clinical Utility of OCT Angiography Jay S. Duker, MD
    8:12
    AM
    Are OCT Angiographic Images the Same among Different Devices? Giovanni Staurenghi, MD
    8:19
    AM
    Sickle Cell Retinopathy: New Findings from OCT/ OCT Angiography Jennifer Irene Lim, MD
    8:26
    AM
    OCT Angiography Smash Hits Nadia Khalida Waheed, MD
    8:33
    AM
    Imaging the Neurovascular Unit Richard F. Spaide, MD
    8:40
    AM
    New Modes of Autofluorescence Imaging Frank G. Holz, MD
    8:47
    AM
    Multimodal Pediatric Retinal Imaging for Vitreoretinal Surgical Planning Cynthia A. Toth, MD
    8:54
    AM
    Swept-Source OCT and OCT Angiography for Pathologic Myopia Kyoko Ohno-Matsui, MD
    9:01
    AM
    Hyper-reflective Foci: A Relevant Biomarker for Macular Disease Activity Ursula M. Schmidt-Erfurth, MD

    Section XIII: Late Breaking Developments, Part II
    Moderators: Hugo Quiroz-Mercado, MD

    9:08 AM Brolucizumab for Neovascular AMD: the 2 Year HAWK and HARRIER Results Pravin U. Dugel, MD
    9:13 AM Use of Intravitreal Aflibercept Treat-and-extend Dosing for Wet Age-related Macular Degeneration: 96-week ALTAIR Results Masahito Ohji, MD
    9:18 AM Identifying Ophthalmological Diagnoses and Treatable Diseases by Image-Based Deep Learning Michael Goldbaum, MD, MS
    9:23 AM Port Delivery System With Ranibizumab (PDS): From Dose Ranging in Ladder Phase 2 to Archway Phase 3 Study Design

    Dante Pieramici, MD

    9:28 AM Subretinal Implantation Of Human Retinal Progenitor Stem Cells (Hrpc) for Retinitis Pigmentosa: Phase I/Ii Interim Safety Results Jason I. Comander, MD, PhD
    9:33 AM  OCT- Angiography Results from the PRO-CON Study: Intravitreal Aflibercept Injection (IAI) versus Sham as Prophylaxis against Conversion to Neovascular  Age-related Macular Degeneration (nAMD) in High-Risk Eyes David M. Brown, MD

    Section XIV: Neovascular AMD
    Moderators: Irene A. Barbazetto, MD 

    9:38
    AM
    Prediction of Retinal Pigment Epithelial Tears: The True Story Nicole Eter, MD
    9:45
    AM
    Twelve-Month Interim Analysis of a Randomized Clinical Trial of Ranibizumab vs. Aflibercept in Neovascular AMD: The RIVAL Study Mark C. Gillies, MD, PhD
    9:52
    AM
    What Is Actually in the Syringe? Accuracy and Precision of Intravitreal Injections of Anti-VEGF in Real Life Anat Loewenstein, MD
    9:59
    AM
    Histopathology of Macular Neovascularization David J. Wilson, MD
    10:06
    AM
    Influence of Choroidal Thickness on Drusen and Exudative AMD Subphenotype Gemmy Chui Ming Cheung, MBBCHIR, FRCOPHTH
    10:13
    AM
    Brolucizumab: Will It Make a Difference? Andrew P. Schachat, MD
    10:20
    AM
    REFRESHMENT BREAK and AAO 2018 EXHIBITS  

    Section XV: Oncology Panel
    Panel Moderator: Prithvi Mruthyunjaya, MD
    Panelists: David H. Abramson, MD, FACS; Colleen M. Cebulla, MD, PhD; Evangelos S. Gragoudas, MD; Tara A. McCannel, MD; Timothy G. Murray, MD, MBA; Amy C. Schefler, MD

    11:00
    AM
    Oncology Panel  

    Section XVI: Diabetes
    Moderators: Lloyd P. Aiello, MD, PhD and Lawrence J. Singerman, MD

    11:20
    AM
    Lessons Learned from DRCR Protocols I, S, T, and U: New Treatment Paradigms for DME and PDR John A. Wells III, MD
    11:27
    AM
    Can We Confidently Predict 2-Year Outcomes in a Patient following 3 Anti-VEGF Injections for Diabetic Macular Edema? Neil M. Bressler, MD
    11:34
    AM
    Five-Year Outcomes for Changes in Diabetic Retinopathy Severity When Treating Diabetic Macula Edema with Ranibizumab: DRCR.net Protocol I Susan B. Bressler, MD
    11:41
    AM
    Regression of Diabetic Retinopathy with Anti-VEGF Treatment: Meta-analysis of 5 Pivotal Clinical Trials Quan Dong Nguyen, MD
    11:48
    AM
    Protocol S: Five-Year Data Jeffrey G. Gross, MD
    11:55
    AM
    What Happens to Patients after They Leave DRCR Network Studies? David J. Browning, MD, PhD
    12:02
    PM
    Anti-VEGF Therapy for Proliferative Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions Mark W. Johnson, MD
    12:09
    PM
    Diabetes Panel Discussion
    Panel Moderator: Judy E. Kim, MD
    Panlelists: J. Fernando Arevalo, MD, FACS; Barbara Ann Blodi, MD; Diana V. Do, MD; Rishi P. Singh, MD; Jennifer K. Sun, MD
     
    12:24
    PM
    LUNCH and AAO 2018 EXHIBITS  

    Section XVII: Innovative Retinal Interventions
    Moderators: Yale L. Fisher, MD and Rajendra S. Apte, MD, PhD

    1:39
    PM
    Nano-retina Marco A. Zarbin, MD, PhD, FACS
    1:46
    PM
    Gene Therapy Szilard Kiss, MD
    1:53
    PM
    An Injectable Fluocinolone Implant for Posterior Uveitis: One-Year Results from Two Phase 3 Clinical Trials Glenn J. Jaffe, MD
    2:00
    PM
    TIE2 Activation in the Management of Diabetic Retinopathy and Diabetic Macular Edema Peter K. Kaiser, MD
    2:07
    PM
    Combined Blockade of Angiopoeitin-2 and VEGF-A with RG7716 in Phase 2 Diabetic Macular Edema and Neovascular AMD Trials: What’s New and What’s to Come Charles C. Wykoff, MD, PhD
    2:14
    PM
    The Art and Science of YAG Vitreolysis Chirag P. Shah, MD, MPH

    Section XVIII: Non-neovascular AMD
    Moderator: Caroline R. Baumal, MD and Catherine A. Cukras, MD, PhD

    2:21
    PM
    Apl-2 Treatment for Geographic Atrophy: Long-term Results David S. Boyer, MD
    2:28
    PM
    A Simple OCT-Based System for Staging Dry AMD Srinivas R. Sadda, MD
    2:35
    PM
    The Natural History of Geographic Atrophy in AREDS2 Emily Y. Chew, MD
    2:42
    PM
    Does the OCT Double Layer Sign in Nonexudative Macular Diseases Indicate Subclinical Neovascularization? Philip J. Rosenfeld, MD, PhD
    2:49
    PM
    Cuticular Drusen: Risk Factors for Advanced AMD Lawrence A. Yannuzzi, MD

    Section XIX: Vitreoretinal Surgery, Part II
    Moderators: Charles C. Barr, MD, FACS and Jonathan L. Prenner, MD

    2:56
    PM
    Endophthalmitis and Pseudoendophthalmitis following Intravitreal Injections Harry W. Flynn Jr., MD
    3:03
    PM
    Anterior Segment Complications of Multiple Intravitreal Injections John T. Thompson, MD
    3:10
    PM
    New Instrumentation David R. Chow, MD
    3:17
    PM
    Case Studies and Management Panel
    Panel Moderator: Dean Eliott, MD
    Panelists: Giampaolo Gini, MD; Carlos Mateo, MD; Kirk H. Packo, MD; Adrienne Williams Scott, MD; Paulo E. Stanga, MD; Paul E. Tornambe, MD
     
    3:37
    PM
    REFRESHMENT BREAK and AAO 2018 EXHIBITS  

    Section XX: Medical Retina, Part II
    Moderator: Jason S. Slakter, MD

    4:15
    PM
    Analysis of the Intestinal Microbiome in Retinal Diseases Sebastian Wolf, MD, PhD
    4:21
    PM
    New Concepts in Classifying Myopic Macular Degeneration Tien Yin Wong, MBBS
    4:28
    PM
    Affordable Stem Cell Therapies Edwin M. Stone, MD, PhD
    4:35
    PM
    ZEBRA Study Executive Summary Alan L. Wagner, MD, FACS
    4:38
    PM
    Medical Retina Panel Discussion
    Panel Moderator: Jose S. Pulido, MD, MS
    Panelists: Usha Chakravarthy, MBBS, PhD; Jay K. Chhablani, MBBS; Karl G. Csaky, MD; James C. Folk, MD; Lihteh Wu, MD; Seung Young Yu, MD, PHD
     

    Section XXI: Video Surgical Complications—What Would You Do?
    Moderator: Kourous Rezaei, MD
    Panelists: Andrew Chang, MD; Ehab N. El Rayes, MD, PhD; Andre V. Gomes, MD; Frank H. Koch MD; Barbara Parolini, MD; Elliott H. Sohn, MD; Asheesh Tewari, MD and Daniele Tognetto, MD

    4:58
    PM
    Silicone Oil Asheesh Tewari, MD
    5:01
    PM
    Discussion  
    5:04 PM
    PM
    Retinal Detachment Surgery Andrew A. Chang, MBBS
    5:07 PM
    PM
    Discussion  
    5:10 PM
    PM
    Perfluoron Andre V. Gomes, MD
    5:13 PM
    PM
    Discussion  
    5:16 PM
    PM
    Anesthesia Daniele Tognetto, MD
    5:19 PM
    PM
    Discussion  
    5:22 PM
    PM
    Macular Surgery Ehab N. El Rayes, MD, PhD
    5:25 PM
    PM
    Discussion  
    5:28
    PM
    Closing Remarks Richard F. Spaide, MD
    Mark S. Humayun, MD, PhD